China's WuXi PharmaTech Schedules Q1 2012 Earnings Release

Submitted by alex.folkenflik on 18 April 2012       WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, announced that it will release financial results for the first quarter of 2012 after the New York Stock Exchange closes on Thursday, May 10, 2012 (which will be Friday morning, May 11, 2012 Shanghai time).  WuXi PharmaTech is a pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.